Thiazole-indole compounds useful as cyclin dependent kinase II inhibitors, for preventing/reducing the severity of epithelial cytotoxicity side-effects (e.g., alopecia, plantar-palmar syndrome, mucositis) induced by chemoptherapy and/or radiation therapy in a patient receiving such therapy.
Sulfanilamide Compounds. VI. N<sup>4</sup>-Acyl-N<sup>1</sup>-heterocyclic Sulfanilamides and N<sup>1</sup>-heterocyclic Sulfanilamides
作者:H. G. Kolloff、James H. Hunter
DOI:10.1021/ja01847a036
日期:1941.2
Thiazoloindolinone compounds
申请人:SmithKline Beechman Corporation
公开号:US06492398B1
公开(公告)日:2002-12-10
Thiazole-indole compounds useful as cyclin dependent kinase 11 inhibitors, for preventing/reducing the severity of epithelial cytotoxicity side-effects (e.g., alopecia, plantar-palmar syndrome, mucositis) induced by chemoptherapy and/or radiation therapy in a patient receiving such therapy.